Clinical features of patients with anti-neutrophil cytoplasmic autoantibodies targeting native myeloperoxidase antigen

By Yamanishi Yuji   Ito-Ihara Toshiko   Nagao Tomokazu   Uno Kazuko   Kobayashi Shigeto   Muso Eri   Shane Peter   Firestein Gary   Hashimoto Hiroshi   Okazaki Tomio   Suzuki Kazuo  

Modern Rheumatology, Vol. 23, Iss. 5, 2013-09 ,pp. : 963-971

Springer Publishing Company

Access to resources Recommend Favorite

Anti-myeloperoxidase antibodies enhance phagocytosis, IL-8 production, and glucose uptake of polymorphonuclear neutrophils rather than anti-proteinase 3 antibodies leading to activation-induced cell death of the neutrophils

By Hsieh S.   Yu H.   Cheng S.   Li K.   Lu M.   Wu C.   Tsai C.   Yu C.  

Clinical Rheumatology, Vol. 26, Iss. 2, 2007-02 ,pp. : 216-224

Springer Publishing Company

Access to resources Recommend Favorite

Role of Neopterin, C-Reactive Protein and Myeloperoxidase in Patients Undergoing Cardiopulmonary Bypass

By  

Medical Principles and Practice, Vol. 19, Iss. 6, 2010-09 ,pp. : 479-484

Karger

Access to resources Recommend Favorite

Role of myeloperoxidase in cardiology

By Ikitimur Baris   Karadag Bilgehan  

Future Cardiology, Vol. 6, Iss. 5, 2010-09 ,pp. : 693-702

Future Medicine

Access to resources Recommend Favorite

Myeloperoxidase: The Good, the Bad, and the Ugly

By  

Current Immunology Reviews, Vol. 6, Iss. 2, 2010-05 ,pp. : 123-129

Bentham Science Publishers

Access to resources Recommend Favorite